Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00420849 · BASELINE

Baseline characteristics

A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma · Source last updated 2012-05-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      587
    units
    Participants
groups
  1. description
    Lenalidomide administered orally, 25 mg daily (QD) for the first 21 days of each 28-day cycle. Pulse dexamethasone administered orally, 40 mg daily on Days 1-4, 9-12, and 17-20 for each 28-day cycle during Cycles 1 to 4 (approximately months 1-4). Beginning with Cycle 5 (approximately month 5), a maintenance dose of dexamethasone (40 mg QD) was administered on Days 1 to 4 of each 28-day cycle.
    id
    BG000
    title
    Lenalidomide Plus Dexamethasone
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          9.74
          value
          64.5
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
      title
      <=18 years
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          314
      title
      >18 and <=65 years
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          273
      title
      >65 years
    param Type
    NUMBER
    title
    Age, Customized
    unit Of Measure
    participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          241
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          346
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          548
      title
      White
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          17
      title
      Other
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          10
      title
      Asian / Pacific Islander
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          9
      title
      Black
    5. categories
      1. measurements
        1. group Id
          BG000
          value
          3
      title
      Hispanic
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    participant
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      587
    units
    Participants
groups
  1. description
    Lenalidomide administered orally, 25 mg daily (QD) for the first 21 days of each 28-day cycle. Pulse dexamethasone administered orally, 40 mg daily on Days 1-4, 9-12, and 17-20 for each 28-day cycle during Cycles 1 to 4 (approximately months 1-4). Beginning with Cycle 5 (approximately month 5), a maintenance dose of dexamethasone (40 mg QD) was administered on Days 1 to 4 of each 28-day cycle.
    id
    BG000
    title
    Lenalidomide Plus Dexamethasone
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          9.74
          value
          64.5
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
      title
      <=18 years
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          314
      title
      >18 and <=65 years
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          273
      title
      >65 years
    param Type
    NUMBER
    title
    Age, Customized
    unit Of Measure
    participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          241
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          346
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          548
      title
      White
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          17
      title
      Other
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          10
      title
      Asian / Pacific Islander
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          9
      title
      Black
    5. categories
      1. measurements
        1. group Id
          BG000
          value
          3
      title
      Hispanic
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    participant

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice